NASDAQ:AMRN
Amarin Corporation PLC Stock News
$0.88
+0.0176 (+2.03%)
At Close: Apr 23, 2024
Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia
12:00pm, Tuesday, 15'th Nov 2022 GlobeNewswire Inc.
-- VAZKEPA® Approved in Australia to Reduce the Risk of CV Events in Adult Statin-Treated Patients with High CV Risk with Elevated Triglycerides -- -- Marks Fifth Regulatory Approval for VASCEPA®/VA
Seagen (SGEN) Adcetris Label Expansion OK'd, New CEO Named
03:23pm, Friday, 11'th Nov 2022 Zacks Investment Research
The FDA approves Seagen's (SGEN) Adcetris for a new indication, treating pediatric patients with previously untreated high-risk Hodgkin lymphoma. The company also appoints a new CEO.
Amarin to Present at Jefferies London Healthcare Conference
08:00am, Wednesday, 09'th Nov 2022
DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin's president and chief executive officer, is sch
Apellis' (APLS) Q3 Earnings Miss Estimates, Revenues Top Mark
04:05pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Apellis' (APLS) earnings miss estimates in the third quarter of 2022 while revenues beat the same.
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
10:00am, Tuesday, 08'th Nov 2022 Benzinga
Gainers
Digital World Acquisition Corp. (NASDAQ: DWAC) shares jumped 66.5% to settle at $29.10 on Monday amid recent reports suggesting Donald Trump could announce a 2024 presidential run this week.
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
05:46pm, Monday, 07'th Nov 2022 Benzinga
Gainers
Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.
Veru Inc. (NASDAQ: VERU) shares jumped 47% to $15.22 following publication of briefing documents ahead of the Nov.
Deciphera's (DCPH) Q3 Loss Narrows, Qinlock Drives Revenues
07:57pm, Friday, 04'th Nov 2022 Zacks Investment Research
Deciphera (DCPH) reports a narrower-than-expected loss for the third quarter of 2022 while revenues beat estimates. Qinlock drives year-over-year sales.
Editas' (EDIT) Q3 Earnings Beat Estimates, Pipeline in Focus
05:11pm, Thursday, 03'rd Nov 2022 Zacks Investment Research
Editas (EDIT) reports a narrower-than-expected loss for the third quarter of 2022. Focus remains on the lead candidate, EDIT-101, as well as other pipeline candidates.
Acadia's (ACAD) Q3 Loss Narrower Than Expected, Revenues Miss
04:23pm, Thursday, 03'rd Nov 2022 Zacks Investment Research
Acadia (ACAD) reports a narrower-than-expected loss in the third quarter of 2022 while revenues fall shy of estimates. Tightens guidance for Nuplazid.
Amarin (AMRN) Q3 Earnings Beat, Sales Hurt by Vascepa Generics
04:02pm, Friday, 28'th Oct 2022 Zacks Investment Research
Amarin's (AMRN) Vascepa sales decline year over year amid rising generic competition and the restructuring initiatives in the third quarter. The stock witnesses a decline on Oct 27.
Amarin (AMRN) Q3 Earnings Beat, Sales Hurt by Vascepa Generics
01:33pm, Friday, 28'th Oct 2022
Amarin's (AMRN) Vascepa sales decline year over year amid rising generic competition and the restructuring initiatives in the third quarter. The stock witnesses a decline on Oct 27.
Amarin (AMRN) Q3 2022 Earnings Call Transcript
07:30pm, Thursday, 27'th Oct 2022 The Motley Fool
AMRN earnings call for the period ending September 30, 2022.
Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update
11:00am, Thursday, 27'th Oct 2022 GlobeNewswire Inc.
-- U.S. Business Trends Stabilize and Progress on Operational Initiatives Result in Extended Cash Runway -- -- Commenced Launch of VAZKEPA® (icosapent ethyl) in England & Wales Mid-October As Planned
Amarin Corporation plc (AMRN) Q3 2022 Results - Earnings Call Transcript
09:49am, Thursday, 27'th Oct 2022
Amarin Corporation plc (NASDAQ:AMRN ) Q3 2022 Results Earnings Conference Call October 27, 2022 8:00 AM ET Company Participants Lisa DeFrancesco - Senior Vice President, Corporate Affairs and Investor
